Live
- GMR Airports Unveils AI-Powered Digital Twin Platform to Transform Airport Operations
- India poised to become leading maritime player: PM Modi
- Top Causes of Kidney Stones and How to Recognize Silent Symptoms
- India’s renewable energy capacity logs 14.2 pc growth at 213.7 GW
- Winter Session of Odisha Assembly adjourned sine die
- Biden calls Trump's tariff approach 'major mistake'
- After Drama Over Eknath Shinde’s Chief Minister Race, Maharashtra Cabinet Formation Faces New Tensions
- Egyptian FM, Blinken discuss recent developments in Syria
- Iran's supreme leader says Syria's developments result of US-Israeli 'plot'
- Elon Musk to Purchase $100 Million Luxury Mansion Next to Donald Trump's Mar-a-Lago, Report Reveals
T-Hub signs MoU with pharmaceutical major Novartis Healthcare
T-Hub, a startup incubator set up by the Telangana Government today said it has signed an MoU with pharmaceutical major Novartis Healthcare Private Ltd (NHPL) to create and execute joint programs that would benefit HealthTech startups from across segments.
Hyderabad: T-Hub, a startup incubator set up by the Telangana Government today said it has signed an MoU with pharmaceutical major Novartis Healthcare Private Ltd (NHPL) to create and execute joint programs that would benefit HealthTech startups from across segments.
Being leaders in healthcare, Novartis will be working together with T-Hub to develop plans and programs that will help health tech, health care and pharmaceutical startups to scale and grow, according to a press release issued by the incubator.
As a part of the initiatives health, research and development experts from Novartis will mentor and guide startups, in compliance with T-Hubs mentorship framework and evaluation process, in their respective ventures, it said.
"We are very excited to collaborate with Novartis. It will bring great value to the ecosystem and HealthTech startups will be greatly benefited. With HealthTech being one of our prime sectors, we are working towards ensuring that startups associated with T-Hub are well mentored and guided through various programs of ours, which will help them scale their business faster," Jay Krishnan, CEO, T-Hub said.
Subodh Deshmukh, Global Drug Development India Head, Novartis said, "As a global leader in biomedical innovation, we are excited about this potential partnership with T-Hub and its allied startups driving innovation in the healthcare space."
